O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
about
Conserved nutrient sensor O-GlcNAc transferase is integral to C. elegans pathogen-specific immunityO-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysisBisubstrate UDP–peptide conjugates as human O-GlcNAc transferase inhibitorsStructural Pathway of Interleukin 1 (IL-1)O-GlcNAcase: promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenumThe role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.TAK1 control of cell death.Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer.Involvement of neuronal TGF-β activated kinase 1 in the development of tolerance to morphine-induced antinociception in rat spinal cord.The active site of O-GlcNAc transferase imposes constraints on substrate sequenceElevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signalingModel Predicts That MKP1 and TAB1 Regulate p38α Nuclear Pulse and Its Basal Activity through Positive and Negative Feedback Loops in Response to IL-1.Dual functionality of O-GlcNAc transferase is required for Drosophila development.NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation.p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly.Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteinsDynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis.TAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer.Defining the structural origin of the substrate sequence independence of O-GlcNAcase using a combination of molecular docking and dynamics simulation.S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway.TAK1, more than just innate immunity.Chemical tools to probe cellular O-GlcNAc signalling.TAK1 regulates hepatic cell survival and carcinogenesis.Direct Monitoring of Protein O-GlcNAcylation by High-Resolution Native Mass SpectrometryA mutant O-GlcNAcase enriches Drosophila developmental regulators.OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.Post-Translational Modifications of the TAK1-TAB Complex.WGA-based lectin affinity gel electrophoresis: A novel method for the detection of O-GlcNAc-modified proteins.Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeatsMyeloid-derived cullin 3 promotes STAT3 phosphorylation by inhibiting OGT expression and protects against intestinal inflammation.TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal.A mutant O-GlcNAcase as a probe to reveal global dynamics of protein O-GlcNAcylation during Drosophila embryonic development.O-GlcNAcylation is required for B cell homeostasis and antibody responses.Synthesis of and specific antibody generation for glycopeptides with arginine N-GlcNAcylation.Interactome analysis of transforming growth factor-β-activated kinase 1 in Helicobacter pylori-infected cells revealed novel regulators tripartite motif 28 and CDC37.Investigation of post-translational modifications in type 2 diabetes
P2860
Q27324552-E4965CAF-A997-4B4F-9A45-0D2222E646E8Q27674743-7F29CFC2-1B09-4CBD-B60A-FE607FFA9F05Q27680651-8CA86925-CF11-4359-843E-B2F5C9A9887BQ30230803-3BB8ADF4-B907-414D-B4C7-DD53DEA2B66AQ30368002-04D57444-5073-4163-BECE-DE793E921108Q30380552-C7B618B3-801A-4CD1-BD09-6C6F2561F6ADQ33683197-68FACA84-BCF2-45F3-938C-761F483658BEQ34413437-0FBE8D62-B739-41C2-B43D-25C65482492DQ35176207-1B513C6C-3D7C-4703-B533-C8D79E3AF27AQ35631488-F0E2332A-A7AF-41F3-B444-4112A61570ACQ35735257-2655D3F6-FD90-4025-959D-9A193581EDF2Q35828619-C09B7DFE-A559-4321-9C09-364321C6B533Q36055446-EE55EC04-ADB2-4214-8C25-89A9ADF5EF97Q36435554-6652AD17-2FD5-4AE3-B414-F89F0DE26B72Q36557738-16EB56CC-A255-4129-8699-8B069F926E7FQ36559764-A7F0BD22-5F87-4523-B8FB-00F99090AB8AQ36990867-292ACD0F-F76D-4C6A-8310-0069BE9C9392Q37099485-66359DA5-120B-49D8-A5E8-8DBD436A82B9Q37225680-03CF0F0C-4895-437A-B03D-33BC2D4413B8Q37371725-09FFA7EB-F7FB-42FF-9EDD-E0DD16986CE5Q37546906-5EA15A13-44D7-4630-9D73-D80D7E529C96Q38040025-C57D2C13-509B-441E-8D5D-A3643CF198ECQ38155213-4A822406-C8E5-4428-B6E8-94E93EA3807DQ38180064-4E7C945D-670C-4B36-8232-CA5F2C3FB29CQ38727716-AB2DD1CD-766A-4581-9655-6ACCB2BA9B13Q38730380-963F0DA7-32F5-4EE6-9308-4ECE2AD89780Q38832460-098E1835-D93E-4685-9B00-D0C933C0B119Q39096576-8507B3F9-4BE8-4989-8EEA-E4B01BC7BDD5Q40960304-6EC74D17-5F0D-4F58-9BA9-47CD5B9029CFQ40984745-5291D408-6C2E-4768-B7B0-AB9F171BFD34Q41978406-60EE1231-9E8B-4A41-8F1A-261B1EBCF136Q42380609-E1E2AD90-6688-412C-8948-8758E3AF04FDQ42425049-80758A19-E48A-40AF-8AFD-E83E34658567Q47113112-F12E770E-75B5-4DD4-93A7-102198F05F9AQ51039252-95B533FC-61F7-465F-A61A-8E1A81D489F5Q52340906-D9D8BF5E-1B0E-4602-9421-60E34762AC2FQ58700790-48942079-D0CF-4679-A1EB-9AC81DF9225E
P2860
O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
@en
O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
@nl
type
label
O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
@en
O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
@nl
prefLabel
O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
@en
O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
@nl
P2093
P2860
P356
P1433
P1476
O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release
@en
P2093
Adel Ibrahim
David G Campbell
Osama Albarbarawi
Shalini Pathak
Vladimir S Borodkin
P2860
P304
P356
10.1038/EMBOJ.2012.8
P407
P577
2012-02-03T00:00:00Z